ArticleJournal of medicinal chemistry2025

Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity.

Sayumi Yamazoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.